Investor Relations
Triller Group Inc. (NASDAQ: “ILLR”) is a US-based company that operates two main businesses, Triller Corp. (“Triller”) and AGBA Group Holding Limited (“AGBA”).
Triller operates a technology platform that is built along three core businesses. The Triller social media platform generates and distributes digital content to its users and provides a suite of innovative AI and SaaS tools that are already used by top creators and global brands across all major social media platforms. BKFC is the world’s fastest growing combat league. TrillerTV is an over-the-top streaming TV streaming platform, which streams more than 3,000 live events annually to households across the globe.
AGBA is a leading Hong Kong-based insurance and wealth distribution platform serving over 400,000 individual and corporate customers. AGBA is organized into four key divisions: the Platform Business, Distribution Business, Healthcare Business and Fintech Business.
Triller & AGBA: A Digital Powerhouse
Explore the details and strategic vision of the AGBA-Triller merger, a transformative partnership set to reshape the industry.
Los Angeles – December 5, 2024 – Triller Group Inc. (Nasdaq: ILLR) (“Triller Group” or “the Company”) is pleased to...
Los Angeles– December 2, 2024 – Triller Group Inc. (Nasdaq: ILLR) (“Triller Group” or “the Company”) revealed a momentous milestone...
Los Angeles – November 27, 2024 – Triller Group Inc. (Nasdaq: ILLR) (“Triller Group” or “the Company”) is thrilled to...
Download the ILLR Fact Sheet
Get a high level overview of the company, our biggest opportunities, and where we’re headed.
Explore the Triller Insights Series
Gain exclusive access to the stories, strategies, and vision shaping Triller’s future. Dive into insightful conversations with our leadership team as we redefine digital entertainment.
SEC Filings
All filings are available via EDGAR.
ILLR Investor Relations YouTube Channel
Visit our YouTube Channel for the latest updates.
Investor Contact
Get the latest investor information and stay informed.